Table 3. Prevalence of chronic kidney disease in the CARRS and MASALA studies.

	Overall		Men		Women
	CARRS	MASALA	CARRS	MASALA	CARRS	MASALA
	N = 5294	N = 748	N = 2563	N = 402	N = 2731	N = 346
Raw Prevalence
CKD	10.5 (9.7–11.4)	16.3 (13.7–19.0)+	10.5 (9.3–11.7)	12.2 (9.0–15.4)	10.6 (9.4–11.7)	21.1 (16.8–25.4)+
Albuminuria	8.6 (7.9–9.4)	15.1 (12.5–17.7)+	8.5 (7.4–9.5)	10.9 (7.9–14.0)	8.8 (7.7–9.8)	19.9 (15.7–24.2)+
eGFR<60	3.1 (2.6–3.6)	2.0 (1.0–3.0)	3.0 (2.3–3.7)	2.2 (0.8–3.7)	3.2 (2.5–3.8)	1.7 (0.4–3.1)
Age-adjusted Prevalence
CKD	10.8 (10.0–11.6)	14.0 (11.8–16.3)+	10.8 (9.6–12.0)	10.3 (7.6–13.0)	10.8 (9.6–11.9)	18.6 (14.9–22.4)+
Albuminuria	8.7 (8.0–9.5)	13.8 (11.4–16.1)+	8.6 (7.5–9.7)	9.8 (7.1–12.6)	8.8 (7.7–9.9)	18.5 (14.5–22.4)+
eGFR<60	3.2 (2.8–3.7)	1.6 (0.8–2.3) +	3.1 (2.5–3.8)	1.7 (0.6–2.8)+	3.2 (2.6–3.9)	1.4 (0.3–2.5)+

Values in table are prevalence % (95% confidence interval).

⁺p value for prevalence difference from CARRS < 0.05